Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,126 | -7,566 | -12,230 | -10,749 | -12,122 |
| Other Working Capital | -10 | -519 | 688 | 277 | 78 |
| Other Operating Activity | 1,374 | 1,106 | 2,825 | 1,764 | 1,548 |
| Operating Cash Flow | $-5,762 | $-6,979 | $-8,717 | $-8,708 | $-10,496 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -4,500 | N/A |
| Common Stock Issued | 6,107 | 4,618 | 7,389 | 13,524 | 5,031 |
| Financing Cash Flow | $6,107 | $4,618 | $7,389 | $9,024 | $5,031 |
| Beginning Cash Position | 5,319 | 7,679 | 9,007 | 8,691 | 14,156 |
| End Cash Position | 5,664 | 5,319 | 7,679 | 9,007 | 8,691 |
| Net Cash Flow | $345 | $-2,360 | $-1,328 | $316 | $-5,465 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,762 | -6,979 | -8,717 | -8,708 | -10,496 |
| Free Cash Flow | -5,762 | -6,979 | -8,717 | -8,708 | -10,496 |